​On October 9, 2019, national and international hepatitis experts and health providers gathered in Nay Pyi Taw, Myanmar, to review the findings of a one-year research project led by Community Partners International (CPI) to assess a simplified antiviral treatment strategy for hepatitis C. Through this project, CPI and partners are seeking to demonstrate that effective treatment of hepatitis C in Myanmar is viable and affordable using new diagnostic and treatment approaches.

​In the run-up to today’s International Harm Reduction Day, the 26th International Harm Reduction Conference (HR19) in Porto, Portugal, came to a close on May 1, 2019. With support from the USAID HIV/AIDS Flagship (UHF) Project, colleagues from Médecins du Monde (MdM), Medical Action Myanmar (MAM), Asian Harm Reduction Network (AHRN), and Community Partners International (CPI) had the opportunity to attend the biannual conference.

Daw Theint Su, a peer educator at Population Services International’s (PSI) TOP Centers (formerly the Targeted Outreach Program), has been living with HIV since 2003. Here she shares her experiences and talks about her work supporting HIV education and prevention.

In cities in Kachin State, HIV prevalence among people who inject drugs (PWID) is nearly 50%.[1] To reduce transmission of HIV and other viruses through the sharing of contaminated needles and syringes, Metta Development Foundation (Metta) is working to increase access to harm reduction services such as the Needle Syringe Exchange Program (NSEP) at drop-in center locations. Harm reduction "is an evidence-based approach to HIV prevention, treatment and care for people who inject drug[s]," and is part of a wider strategy to address the high HIV prevalence among PWID in Kachin State. These services are supported by the USAID HIV/AIDS Flagship (UHF) Project, funded by USAID under PEPFAR through UNAIDS Myanmar with project implementation support and management to partner organizations. provided by Community Partners International (CPI).